Literature DB >> 23623274

Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells.

Martina Bernardi1, Elena Albiero, Alberta Alghisi, Katia Chieregato, Chiara Lievore, Domenico Madeo, Francesco Rodeghiero, Giuseppe Astori.   

Abstract

BACKGROUND AIMS: A medium supplemented with fetal bovine serum (FBS) is of common use for the expansion of human mesenchymal stromal cells (MSCs). However, its use is discouraged by regulatory authorities because of the risk of zoonoses and immune reactions. Human platelet lysate (PL) obtained by freezing/thawing disruption of platelets has been proposed as a possible substitute of FBS. The process is time-consuming and not well standardized. A new method for obtaining PL that is based on the use of ultrasound is proposed.
METHODS: Platelet sonication was performed by submerging platelet-containing plastic bags in an ultrasonic bath. To evaluate platelet lysis we measured platelet-derived growth factor-AB release. PL efficiency was tested by expanding bone marrow (BM)-MSCs, measuring population doubling time, differentiation capacity and immunogenic properties. Safety was evaluated by karyotyping expanded cells.
RESULTS: After 30 minutes of sonication, 74% of platelet derived growth factor-AB was released. PL enhanced BM-MSC proliferation rate compared with FBS. The mean cumulative population doubling (cPD) of cells growth in PL at 10%, 7.5% and 5% was better compared with cPD obtained with 10% FBS. PD time (hours) of MSCs with PL obtained by sonication was shorter than for cPD with PL obtained by freezing/thawing (18.9 versus 17.4, P < 0.01). BM mononucleated cells expressed MSC markers and were able to differentiate into adipogenic, osteogenic and chondrogenic lineages. When BM-MSCs and T cells were co-cultured in close contact, immunosuppressive activity of BM-MSCs was maintained. Cell karyotype showed no genetic alterations.
CONCLUSIONS: The proposed method for the production of PL by sonication could be a safe, efficient and fast substitute of FBS, without the potential risks of FBS.
Copyright © 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PDGF-AB; mesenchymal stromal cell; platelet lysate; sonication

Mesh:

Substances:

Year:  2013        PMID: 23623274     DOI: 10.1016/j.jcyt.2013.01.219

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  24 in total

1.  Serum and xeno-free, chemically defined, no-plate-coating-based culture system for mesenchymal stromal cells from the umbilical cord.

Authors:  Xiaoyun Wu; Huiyan Kang; Xuemin Liu; Jin Gao; Kuijun Zhao; Zhijie Ma
Journal:  Cell Prolif       Date:  2016-08-04       Impact factor: 6.831

2.  Culture of human cell lines by a pathogen-inactivated human platelet lysate.

Authors:  R Fazzina; P Iudicone; A Mariotti; D Fioravanti; A Procoli; E Cicchetti; G Scambia; G Bonanno; L Pierelli
Journal:  Cytotechnology       Date:  2015-05-06       Impact factor: 2.058

3.  Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Thuy Thi-Thanh Dao; Ha Thi-Ngan Le; Lan Thi Phi; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-24       Impact factor: 2.416

4.  Efficient isolation and proliferation of human adipose-derived mesenchymal stromal cells in xeno-free conditions.

Authors:  Natalia Langenfeld Fuoco; Rafael Guilen de Oliveira; Monica Yonashiro Marcelino; Talita Stessuk; Marna Eliana Sakalem; Denis Aloisio Lopes Medina; Waldir Pereira Modotti; Andresa Forte; João Tadeu Ribeiro-Paes
Journal:  Mol Biol Rep       Date:  2020-03-02       Impact factor: 2.316

Review 5.  Human platelet lysate - A potent (and overlooked) orthobiologic.

Authors:  Lucas da Fonseca; Gabriel Silva Santos; Stephany Cares Huber; Taís Mazzini Setti; Thiago Setti; José Fábio Lana
Journal:  J Clin Orthop Trauma       Date:  2021-07-28

Review 6.  Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center.

Authors:  David F Stroncek; Marianna Sabatino; Jiaqiang Ren; Lee England; Sergei A Kuznetsov; Harvey G Klein; Pamela G Robey
Journal:  Tissue Eng Part B Rev       Date:  2014-02-07       Impact factor: 6.389

7.  Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents.

Authors:  Neil H Riordan; Marialaura Madrigal; Jason Reneau; Kathya de Cupeiro; Natalia Jiménez; Sergio Ruiz; Nelsy Sanchez; Thomas E Ichim; Francisco Silva; Amit N Patel
Journal:  J Transl Med       Date:  2015-07-17       Impact factor: 5.531

8.  Effect of platelet lysate on human cells involved in different phases of wound healing.

Authors:  Maria Chiara Barsotti; Maria Chiara Barsotti; Paola Losi; Enrica Briganti; Elena Sanguinetti; Angela Magera; Tamer Al Kayal; Roberto Feriani; Rossella Di Stefano; Giorgio Soldani
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 9.  Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future.

Authors:  Giuseppe Astori; Eliana Amati; Franco Bambi; Martina Bernardi; Katia Chieregato; Richard Schäfer; Sabrina Sella; Francesco Rodeghiero
Journal:  Stem Cell Res Ther       Date:  2016-07-13       Impact factor: 6.832

10.  Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approach.

Authors:  Francesco Agostini; Jerry Polesel; Monica Battiston; Elisabetta Lombardi; Stefania Zanolin; Alessandro Da Ponte; Giuseppe Astori; Cristina Durante; Mario Mazzucato
Journal:  J Transl Med       Date:  2017-05-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.